Myelin formation is the process by which oligodendrocytes (in the CNS) and Schwann cells (in the PNS) wrap neuronal axons with a multi-layered lipid-rich membrane. This process is essential for rapid saltatory conduction of action potentials and provides metabolic support to axons. Dysregulation of myelin formation and maintenance is implicated in various neurodegenerative diseases including multiple sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis .
Oligodendrocytes are the myelin-forming cells in the central nervous system:
- Progenitor cells (OPCs): NG2-positive cells that proliferate and differentiate into mature oligodendrocytes
- Mature oligodendrocytes: Myelinating cells expressing PLP (proteolipid protein), MBP (myelin basic protein), and MOG (myelin oligodendrocyte glycoprotein)
- Myelination capacity: Single oligodendrocyte can myelinate up to 60 axon segments
Schwann cells myelinate peripheral nerve fibers:
- Myelinating Schwann cells: Wrap larger diameter axons (>1μm) with compact myelin
- Non-myelinating Schwann cells: Support Remak bundles of small unmyelinated axons
- Repair Schwann cells: Dedifferentiated cells that support nerve regeneration
MBP is the major protein component of CNS myelin:
- Function: Provides the structural framework for myelin compaction
- Post-translational modifications: Phosphorylation, citrullination affect protein function
- Localization: Cytoplasmic surface of myelin membrane
- Diseases: Mutations cause Pelizaeus-Merzbacher disease
PLP and its isoform DM20 are abundant CNS myelin proteins:
- Function: Stabilize myelin structure and oligodendrocyte survival
- Topology: Tetraspan protein spanning the myelin membrane
- Mutations: Cause Pelizaeus-Merzbacher disease (X-linked)
MYRF is a transcription factor essential for myelination:
- Function: Regulates expression of myelin genes (MBP, PLP, MAG)
- Auto-cleavage: Self-cleaving transcription factor activated by cholesterol
- Requirement: Essential for oligodendrocyte differentiation
| Protein |
Gene |
Function |
| Myelin oligodendrocyte glycoprotein (MOG) |
MOG |
Surface marker, autoimmune target |
| Myelin-associated glycoprotein (MAG) |
MAG |
Axon-oligodendrocyte adhesion |
| Oligodendrocyte-myelin glycoprotein (OMG) |
OMG |
Neuronal survival, myelination |
| CNP (2',3'-cyclic nucleotide 3'-phosphodiesterase) |
CNP |
Process outgrowth, mitochondria support |
- PDGF-AA promotes OPC proliferation via PDGFRα
- PDGF-BB attracts OPCs to axon segments
- Dysregulation leads to hypomyelination
- T3 (triiodothyronine) is essential for oligodendrocyte differentiation
- T3 receptor mutants cause hypothyroidism and hypomyelination
- Thyroid hormone response elements in MBP and PLP promoters
- Wnt signaling inhibits OPC differentiation temporally
- β-catenin levels regulate myelination timing
- Dysregulation implicated in demyelinating diseases
- Cholesterol is essential for myelin membrane formation
- LXR agonists promote myelination
- Demyelination reduces cholesterol synthesis
- Neurexin-Neuroligin interactions initiate axon-glial contact
- TAG-1 and L1CAM mediate initial adhesion
- Galactocerebroside on oligodendrocyte surface binds axonal receptors
- Cytoskeletal reorganization drives membrane sheet extension
- Actin polymerization at leading edge
- Microtubule network supports membrane trafficking
- MBP localizes to cytoplasmic channels
- PLP traffics via Golgi-dependent pathway
- Compaction removes cytoplasmic layers
¶ Step 4: Radial and Longitudinal Growth
- MLC phosphorylation regulates water flux
- Neurofilament phosphorylation increases axon diameter
- Internodal length increases with maturation
- White matter lesions common in AD brains
- Oligodendrocyte dysfunction contributes to Aβ accumulation
- Myelin breakdown products found in amyloid plaques
- Widespread demyelination correlates with cognitive decline
- Oligodendrocyte loss in substantia nigra
- Myelin abnormalities detected in PD white matter
- α-synuclein can be internal oligodendrocytes
- GBA mutations affect oligodendrocyte function
- Oligodendrocyte degeneration precedes motor neuron loss
- Reduced MBP in motor cortex
- OPC dysfunction in ALS models
- Energy support failure from oligodendrocytes
- Autoimmune demyelination is the primary pathology
- Remyelination failure leads to permanent disability
- OPCs become senescent in chronic lesions
- Therapies target both immune modulation and repair
- Lingo-1 antagonists: Anti-Lingo-1 antibody (opicinumab) in trials
- mTOR activators: Promoting OPC differentiation
- cAMP elevation: Rolipram enhances remyelination
- Statins: Cholesterol-independent remyelination effects
- Bexarotene: LXR agonist promoting myelination
- Clemastine: Antihistamine promoting OPC differentiation
- Miconazole: Steroid promoting remyelination
- OPC transplantation: Clinical trials in MS patients
- iPSC-derived oligodendrocytes: Potential cell therapy
- Schwann cell transplantation: For PNS repair
- Single-cell atlases of oligodendrocyte lineages
- Novel remyelination promoters in clinical trials
- Gene therapy for leukodystrophies
- Nanoparticle delivery of myelination-promoting drugs
- Age-related demyelination as therapeutic target
This section highlights recent publications relevant to this mechanism.